Chronic kidney disease trials recruiting in District of Columbia

All Chronic kidney disease trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
  NCT05321368 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
  NCT06830629 · Phase: Phase 2 · Ages: 18 Years to 68 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
  NCT05457283 · Phase: Phase 3 · Ages: 1 Year to 18 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
  NCT05655325 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
  NCT06110130 · Phase: Phase 4 · Ages: 19 Years to 90 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease
  NCT04397159 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 85 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
  NCT06422871 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.